In this issue of Respiratory Care, Siobal and colleagues report on the correlation, precision, and bias of calculated physiologic dead space, determined using the volumetric capnography module available in the Dräger XL ventilator, compared to other methods (metabolic analyzer and volumetric CO2 monitor).1 It is important to note that the investigators choose comparative technologies that reflect the standard of care for monitoring the ratio of dead space to tidal volume (VD/VT) at many institutions. Volumetric capnography is a relatively new addition to mechanical ventilators. Through their investigation, Siobal and colleagues demonstrate a high degree of association between the VD/VT derived through the Dräger ventilator module (using volumetric capnography) and other comparative technologies (Deltatrac, Metascope, Vmax Encore, and NICO2).
In a comparison of 67 measurements obtained from 36 mechanically ventilated adult patients, all of whom were recovering from acute lung injury or ARDS, the overall correlation between the Dräger derived VD/VT and that of the metabolic analyzers was r = 0.96, with a bias of −0.19 and precision of ± 0.03. The authors appropriately conclude from their study that the Dräger XL's volumetric capnography measurements can accurately calculate VD/VT without the use of a metabolic analyzer or volumetric CO2 monitor. This study demonstrates that the volumetric CO2 module incorporated into the Dräger XL ventilator can be employed to determine physiologic dead space. However, the question still needs to be answered: Should we monitor physiologic dead space in our ventilated patient population? In other words, what evidence supports the use of VD/VT as a monitor of ventilator efficiency?
As Siobal and colleagues point out, dead-space ventilation was first described by Bohr in 1891,2 and subsequently modified by Enghoff in 1938.3 For over 100 years, researchers and clinicians have been aware of the concept of VD/VT. Initially, the required technology was limited and cumbersome, making clinical utilization of VD/VT impractical. Within the last 4 decades, advances in mechanical ventilation and expiratory gas analysis have aided efforts to investigate VD/VT as a marker of lung function in a variety of patient conditions and populations.4–14 The most recent technological advances have included the incorporation of volumetric capnography as a mechanical ventilator module.15,16 These advances allow for continuous assessment of carbon dioxide production (V̇CO2) and the mixed exhaled pressure of carbon dioxide (PECO2). The addition of the ventilator module should allow practitioners to advance our questions pertaining to the utility of VD/VT in ventilator management of our patients.
It is clear that our profession and the medical field in general have provided adequate verification that current technology for measurement of VD/VT provides comparable results, when compared to prior technological standards. The work of Siobal and colleagues1 serves to advance our confirmation that the newest addition to VD/VT monitoring, specifically volumetric capnography employed by the Dräger XL, is a viable alternative to VD/VT estimation via other means. The real challenge for us as respiratory care practitioners is to apply our knowledge to assess the clinical utility of this measurement in ventilator management. At present, the body of knowledge that describes the relationship between changing pulmonary function, ventilator support, and VD/VT is inadequate to adopt VD/VT as a standard of care. This fact is acknowledged by the authors in their conclusion.
If VD/VT assessment demonstrates a strong association with pulmonary function modulation and ventilator manipulation, then we should adopt VD/VT as a new paradigm in ventilator monitoring. On the other hand, if we fail to demonstrate such an association, then VD/VT becomes just another “Field of Dreams” modality. The responsibility to define the practical uses for VD/VT resides with us, the respiratory care practitioner, and our healthcare partners.
Footnotes
- Correspondence: Ronald E Dechert DrPH MSc RRT FAARC, Pediatric Respiratory Care, CS Mott Hospital, University of Michigan, 200 E Hospital Drive, F5815, Ann Arbor MI 48109. E-mail: rdechert{at}umich.edu.
The author has disclosed no conflicts of interest.
See the Original Study on Page 1143
- Copyright © 2013 by Daedalus Enterprises